Neoadjuvant Therapy of Colorectal Liver Metastases: Lessons Learned from Clinical Trials

被引：14

作者：

Brouquet, Antoine ^{[1
]}

Nordlinger, Bernard ^{[1
]}

机构：

[1] Univ Versailles St Quentin Yvelines, Hop Ambroise Pare, AP HP, Dept Digest & Oncol Surg, Versailles, France

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2010年 / 102卷 / 08期

关键词：

colorectal cancer; liver metastases; chemotherapy; OXALIPLATIN-BASED CHEMOTHERAPY; MULTICENTER RANDOMIZED-TRIAL; HEPATIC ARTERIAL INFUSION; LONG-TERM SURVIVAL; PHASE-III TRIAL; PREOPERATIVE CHEMOTHERAPY; SURGICAL RESECTION; 1ST-LINE TREATMENT; PATHOLOGICAL RESPONSE; FOLINIC ACID;

D O I：

10.1002/jso.21657

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Neoadjuvant chemotherapy is increasingly used to improve outcome in patients with colorectal liver metastases (CLM). In patients with unresectable CLM, recent clinical trials evaluate the ability of chemotherapy to increase the resectability rate. In patients with resectable CLM, the objective is to decrease the risk of recurrence after hepatectomy that still remains elevated despite the improvement of the surgical technique. A multidisciplinary approach of patients with CLM is desirable whatever the initial status of resectability. J. Surg. Oncol. 2010; 102: 932-936. (C) 2010 Wiley-Liss, Inc.

引用

页码：932 / 936

页数：5

共 50 条

[21] Transarterial Therapy for Colorectal Liver Metastases
Bhutiani, Neal
Martin, Robert C. G., II
SURGICAL CLINICS OF NORTH AMERICA, 2016, 96 (02) : 369 - +
[22] Computed tomographic morphological evaluation of neoadjuvant chemotherapy. Effectiveness of the therapy for colorectal liver metastases
Folprecht, G.
Weitz, J.
Hoffmann, R-T
CHIRURG, 2014, 85 (01): : 31 - 36
[23] Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
Ichida, Hirofumi
Mise, Yoshihiro
Ito, Hiromichi
Ishizawa, Takeaki
Inoue, Yosuke
Takahashi, Yu
Shinozaki, Eiji
Yamaguchi, Kensei
Saiura, Akio
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
[24] The management of resectable and unresectable liver metastases from colorectal cancer
Kemeny, Nancy
CURRENT OPINION IN ONCOLOGY, 2010, 22 (04) : 364 - 373
[25] Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives
Riesco-Martinez, Maria C.
Modrego, Andrea
Espinosa-Olarte, Paula
La Salvia, Anna
Garcia-Carbonero, Rocio
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (09) : 1320 - 1337
[26] Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy
Dunet, Vincent
Halkic, Nermin
Prior, John O.
Anaye, Anass
Meuli, Reto A.
Sempoux, Christine
Denys, Alban
Schmidt, Sabine
CLINICAL NUCLEAR MEDICINE, 2017, 42 (04) : 258 - 263
[27] Neoadjuvant chemotherapy or primary surgery for colorectal liver metastases. Pro adjuvant chemotherapy
Lordick, F.
Knoedler, M.
Hacker, U.
Bartels, M.
CHIRURG, 2014, 85 (01): : 11 - 16
[28] Neoadjuvant chemotherapy or primary surgery for colorectal liver metastases. Pro adjuvant chemotherapy
Lordick, F.
Knoedler, M.
Hacker, U.
Bartels, M.
CHIRURG, 2014, 85 (01): : 11 - 16
[29] Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases
Brunsell, Tuva Host
Cengija, Vanja
Sveen, Anita
Bjornbeth, Bjorn Atle
Rosok, Bard, I
Brudvik, Kristoffer Watten
Guren, Marianne Gronlie
Lothe, Ragnhild A.
Abildgaard, Andreas
Nesbakken, Arild
EJSO, 2019, 45 (12): : 2340 - 2346
[30] Optimum Chemotherapy Regimens for Neoadjuvant Therapy of Hepatic Colorectal Metastases
Davies, Janine M.
Goldberg, Richard M.
JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (08) : 946 - 954

← 1 2 3 4 5 →